Petros Pharmaceuticals, Inc.
PTPI
$0.0198
-$0.0381-65.80%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.71M | 3.89M | 7.46M | 11.08M | 13.34M |
| Total Receivables | 416.10K | 1.95M | 1.78M | 1.96M | 2.23M |
| Inventory | 3.00M | 3.05M | 2.85M | 2.74M | 2.79M |
| Prepaid Expenses | 162.70K | 404.20K | 628.10K | 1.10M | 1.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.50K | 1.42M | 1.27M | 1.03M | 816.20K |
| Total Current Assets | 7.29M | 10.72M | 13.98M | 17.90M | 20.39M |
|
|
|||||
| Total Current Assets | 7.29M | 10.72M | 13.98M | 17.90M | 20.39M |
| Net Property, Plant & Equipment | 136.70K | 143.70K | 177.60K | 217.00K | 255.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.20M | 6.83M | 7.54M | 8.26M | 8.97M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 3.00M | 3.47M | 3.94M | 4.18M |
| Total Assets | 10.64M | 20.69M | 25.17M | 30.31M | 33.80M |
|
|
|||||
| Total Accounts Payable | 2.33M | 1.60M | 791.10K | 2.14M | 1.71M |
| Total Accrued Expenses | 1.29M | 1.24M | 1.73M | 1.76M | 1.18M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.31M | 2.33M | 1.94M | 1.55M | 1.28M |
| Total Finance Division Other Current Liabilities | 7.10M | 7.40M | 5.52M | 5.77M | 6.59M |
| Total Other Current Liabilities | 7.10M | 7.40M | 5.52M | 5.77M | 6.59M |
| Total Current Liabilities | 18.03M | 12.56M | 9.98M | 11.22M | 10.77M |
|
|
|||||
| Total Current Liabilities | 18.03M | 12.56M | 9.98M | 11.22M | 10.77M |
| Long-Term Debt | -- | 4.92M | 5.70M | 6.46M | 6.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 75.20K | 91.80K | 107.80K | 123.00K | 137.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 202.00K | 1.82M | 3.55M |
| Total Liabilities | 18.10M | 17.58M | 15.98M | 19.62M | 21.32M |
|
|
|||||
| Common Stock & APIC | 105.74M | 107.05M | 109.78M | 110.84M | 110.96M |
| Retained Earnings | -113.21M | -103.93M | -101.71M | -101.05M | -98.89M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -7.47M | 3.12M | 8.07M | 9.79M | 12.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 1.40K | 1.12M | 907.00K | 409.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 1.40K | 1.12M | 907.00K | 409.00K |
|
|
|||||
| Total Common Equity | -7.47M | 3.12M | 8.07M | 9.79M | 12.07M |
| Total Preferred Equity | -- | 1.40K | 1.12M | 907.00K | 409.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.47M | 3.12M | 9.19M | 10.69M | 12.48M |
|
|
|||||